Abstract:Fungi are ubiquitous. Yet, despite our frequent exposure to commensal fungi of the normal mammalian microbiota and environmental fungi, serious, systemic fungal infections are rare in the general population. Few, if any, fungi are obligate pathogens that rely on infection of mammalian hosts to complete their lifecycle; however, many fungal species are able to cause disease under select conditions. The distinction between fungal saprophyte, commensal, and pathogen is artificial and heavily determined by the ability of an individual host's immune system to limit infection. Dramatic examples of commensal fungi acting as opportunistic pathogens are seen in hosts that are immune compromised due to congenital or acquired immune deficiency. Genetic variants that lead to immunological susceptibility to fungi have long been sought and recognized. Decreased myeloperoxidase activity in neutrophils was first reported as a mechanism for susceptibility to <i>Candida</i> infection in 1969. The ability to detect genetic variants and mutations that lead to rare or subtle susceptibilities has improved with techniques such as single nucleotide polymorphism (SNP) microarrays, whole exome sequencing (WES), and whole genome sequencing (WGS). Still, these approaches have been limited by logistical considerations and cost, and they have been applied primarily to Mendelian impairments in anti-fungal responses. For example, loss-of-function mutations in <i>CARD9</i> were discovered by studying an extended family with a history of fungal infection. While discovery of such mutations furthers the understanding of human antifungal immunity, major Mendelian susceptibility loci are unlikely to explain genetic disparities in the rate or severity of fungal infection on the population level. Recent work using unbiased techniques has revealed, for example, polygenic mechanisms contributing to candidiasis. Understanding the genetic underpinnings of susceptibility to fungal infections will be a powerful tool in the age of personalized medicine. Future application of this knowledge may enable targeted health interventions for susceptible individuals, and guide clinical decision making based on a patient's individual susceptibility profile.

Advances in research on immunology of fungal infection

Immune Interactions with Pathogenic and Commensal Fungi

When the Fight Against Fungi Goes Wrong

Immunity to fungi and vaccine considerations

Immunity to fungi in the lung

Fungal Influence on Immune Cells and Inflammatory Responses in the Tumor Microenvironment (Review)

Innate immune signal transduction pathways to fungal infection: Components and regulation

DIAGNOSIS AND PREVENTION OF INVASIVE FUNGAL INFECTIONS IN THE IMMUNOCOMPROMISED HOST

Antifungal Innate Immunity: A Perspective from the Last 10 Years

Adaptive immunology of Cryptococcus neoformans infections—an update

Clinical Research of Fungal Infection in 296 AIDS Patients

Cutaneous and subcutaneous fungal infections: recent developments on host-fungus interactions

Immunology of fungal infections in animals

New focus on microecology: intestinal fungi

Intestinal fungi and systemic autoimmune diseases

Research Advances in Medical Mycology

Advances in Understanding Human Genetic Variations That Influence Innate Immunity to Fungi

The advances in the regulation of immune microenvironment by Candida albicans and macrophage cross-talk

An Update on Drug Resistance of Fungal Pathogens

Autoimmune Diseases and Fungal Infections: Immunological Mechanisms and Therapeutic Approaches.

Dermatophyte infection: from fungal pathogenicity to host immune responses